Diametric Capital, LP - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 208 filers reported holding GW PHARMACEUTICALS PLC in Q4 2017. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.

Quarter-by-quarter ownership
Diametric Capital, LP ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2019$332,000
-46.7%
1,967
-69.2%
0.26%
-45.7%
Q4 2018$623,000
-37.9%
6,394
+10.1%
0.48%
-44.9%
Q3 2018$1,004,000
+24.6%
5,810
-4.8%
0.87%
+78.5%
Q4 2017$806,0006,1020.49%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q4 2017
NameSharesValueWeighting ↓
VHCP Management, LLC 311,853$25,213,00011.33%
Iguana Healthcare Management, LLC 50,000$4,043,0002.16%
Ghost Tree Capital, LLC 35,000$2,830,0001.54%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 354,278$28,643,0001.06%
Cupps Capital Management, LLC 100,213$8,102,0000.75%
CLOUGH CAPITAL PARTNERS L P 192,600$15,572,0000.58%
FARALLON CAPITAL MANAGEMENT LLC 244,000$19,727,0000.32%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 105,200$8,505,0000.31%
Eventide Asset Management 25,000$2,021,0000.28%
PRUDENTIAL PLC 836,124$67,601,0000.28%
View complete list of GW PHARMACEUTICALS PLC shareholders